Shares of BioPharma Credit PLC (OTCMKTS:BOPCF – Get Free Report) dropped 4.8% during mid-day trading on Thursday . The company traded as low as $0.8661 and last traded at $0.8661. Approximately 52,000 shares traded hands during trading, an increase of 98% from the average daily volume of 26,250 shares. The stock had previously closed at $0.9095.
BioPharma Credit Stock Performance
The company has a 50 day moving average price of $0.87 and a 200 day moving average price of $0.90.
About BioPharma Credit
BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.
Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms.
Read More
- Five stocks we like better than BioPharma Credit
- Your Bank Account Is No Longer Safe
- When to buy gold (mathematically)
- What a Former CIA Agent Knows About the Coming Collapse
- Nervous about the stock market? Read this
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
